No Data
No Data
Truist Financial Maintains Caribou Biosciences(CRBU.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Caribou Biosciences (CRBU), Olema Pharmaceuticals (OLMA) and Privia Health Group (PRVA)
Truist Financial Remains a Buy on Caribou Biosciences (CRBU)
Truist Removes Price Target on Caribou Biosciences, Keeps Buy Rating; Price Target Was $19
Express News | HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target
Caribou Biosciences Analyst Ratings
HOHA888 : Hi what do you think is a good TP target? My average is around $1.50
FattyChick OP HOHA888 : >1.70
HOHA888 FattyChick OP : okay thanks!
FattyChick OP HOHA888 : Long term >$6
HOHA888 FattyChick OP : Long term as in? Abt half a year?
View more comments...